Central Sterile Corneal Ulceration Clinical Presentation
- Author: Saadia Zohra Farooqui, MBBS; Chief Editor: Hampton Roy Sr, MD more...
History
- In diagnosing this condition, differentiating between infectious and noninfectious etiologies is crucial. Since the clinical management of any corneal ulcer is dependent on its etiology, obtaining all of the salient factors (eg, endogenous, exogenous, local) is important. Therapies for sterile persistent ulcerations should be considered only after adequately addressing infectious and systemic factors.
- Key points to assess in obtaining the history of a patient with a corneal ulcer include the following:
- Prior ocular history - Prior ocular and adnexal surgery, recurrent episodes or infections (eg, herpes), and corneal dystrophy
- Past medical history - Immune status, collagen vascular diseases, systemic infections, diabetes, malnutrition, alcoholism, and chronic debilitating diseases
- History of trauma - Foreign bodies and their origin (eg, soil, vegetation, water), chemical splashes, and lid lacerations
- Contact lens use - Type, frequency, duration, overnight use, and hygiene
- Medications - Ocular and otherwise
- History of present illness - Duration, ocular symptoms (eg, degree of pain vs clinical impression), and chronicity
- Social history - Patient from an area endemic for certain infectious processes, nutritional status, and any alcohol abuse
- The etiology of a sterile ulcer is often multifactorial; in this setting, identifying the coconspirators in this process is important. A thorough evaluation to identify potential factors, including medications (medicamentosa), impaired corneal sensation (neurotrophic), exposure (eg, lagophthalmos), and reduced tear production (sicca), is necessary in most cases of persistent noninfectious ulceration.
Physical
- The physical examination should begin with a gestalt impression of the entire patient, with attention to the following:
- General health of the patient - Skin lesions, skeletal abnormalities, mental status, degree of discomfort, hearing aids, scars, and limitations to ambulation that may indicate a systemic illness
- Local ocular adnexa and related organs - Eyelids, lacrimal system, blink rate, scars, mucous membranes (eg, lips/mouth, conjunctiva), orbit, symmetry, and evidence of inflammation or infection
- Palpation - If indicated for orbital resiliency (thyroid/exposure), lymphadenopathy, and lacrimal or other adnexal masses
- Observation - Lagophthalmos and blink rate
- Assessment of vital signs of the eye - Visual function, corneal sensation, tonometry, pupil function, and motility of the eye (Corneal sensation should be checked prior to tonometry.)
- On slit lamp examination of the cornea, note the appearance of and evaluate the following:
- Conjunctiva, sclera, and lids - Erythema, pattern of injection (ciliary flush, diffuse or deep), perilimbal nodules, discharge, lid closure, lid margin disease, and flipped upper lid to exclude foreign body and floppy eyelid syndrome
- Tear film - Degree, symmetry, regularity, and presence of debris
- Epithelium - Location of epithelial defect (localized or diffuse), regularity, and microcysts
- Stroma - Thinning and presence/pattern of infiltrates (eg, ring, feathery, radial)
- Endothelium - Keratic precipitates
- Anterior chamber - Hypopyon and inflammation
- Corneal sensation
- Symmetry between the eyes
- Fluorescein examination
- Dilated examination (if necessary)
Causes
A thorough history and physical examination should allow a clinician to narrow down the differential diagnosis.
- Infectious causes (which need to be ruled out first) include the following:
- Bacterial (focal infiltrate)
- Fungal (vegetable matter, eg, branch; appearance of satellite lesions; feathery borders to infiltrate; chronic)
- Acanthamoeba (contact lens wear, tap water, soil, severe pain out of proportion to the appearance, radial keratitis, ring ulcer)
- Herpes simplex virus (history, dendrites, decreased sensation, disciform keratitis, increased intraocular pressure)
- Herpes zoster virus (vesicles over dermatome; pseudodendrites, no true terminal bulbs; decreased sensation; increased intraocular pressure)
- Contact lens related (infectious or noninfectious)
- Noninfectious causes include the following:
- Chemical burns, including alkali/acid burn (check pH)
- Thermal/radiation burns (history)
- Sicca (filaments, Sjögren syndrome)
- Neurotrophic (decreased sensation, may have minimal pain, rolled edges, oval, lower one half of cornea, may be quite thin, herpes zoster virus/herpes simplex virus, postsurgery, fifth-nerve palsy, chemical burns, abuse of topical anesthetics, neurotrophic keratitis, diabetes mellitus, multiple sclerosis)[16]
- Exposure (lagophthalmos, lid abnormalities, inadequate blink, facial palsy, proptosis, thyroid disease)
- Medicamentosa (drops)
- Atopic (history, follicles/papillae)
- Vitamin A deficiency (primary deficiency due to prolonged dietary deprivation; secondary deficiency due to diseases that interfere with fat absorption and storage, eg, celiac disease, cystic fibrosis, cholestasis)
- Basement membrane abnormalities (microcysts, evidence of map-dot-fingerprint or anterior stromal dystrophies, history of trauma, other dystrophy)
- Factitious
- Immune-related causes (usually peripheral) include the following:
- Wegener granulomatosis
- Rheumatoid arthritis
- Other collagen vascular diseases (indicated from history and associated systemic findings)
Wentworth JS, Paterson CA, Gray RD. Effect of a metalloproteinase inhibitor on established corneal ulcers after an alkali burn. Invest Ophthalmol Vis Sci. Jun 1992;33(7):2174-9. [Medline].
Gabison EE, Mourah S, Steinfels E, et al. Differential expression of extracellular matrix metalloproteinase inducer (CD147) in normal and ulcerated corneas: role in epithelio-stromal interactions and matrix metalloproteinase induction. Am J Pathol. Jan 2005;166(1):209-19. [Medline].
Shimmura S, Igarashi R, Yaguchi H, et al. Lecithin-bound superoxide dismutase in the treatment of noninfectious corneal ulcers. Am J Ophthalmol. May 2003;135(5):613-9. [Medline].
Tripathi BK, Stepp MA, Gao CY, et al. The Cdk5 inhibitor olomoucine promotes corneal debridement wound closure in vivo. Mol Vis. Mar 17 2008;14:542-9. [Medline].
Sigelman S, Friedenwald JS. Mitotic and wound-healing activities of the corneal epithelium; effect of sensory denervation. AMA Arch Ophthalmol. Jul 1954;52(1):46-57. [Medline].
Nakamura M, Chikama T, Nishida T. Synergistic effect with Phe-Gly-Leu-Met-NH2 of the C-terminal of substance P and insulin-like growth factor-1 on epithelial wound healing of rabbit cornea. Br J Pharmacol. May 1999;127(2):489-97. [Medline].
Bonini S, Lambiase A, Rama P, et al. Topical treatment with nerve growth factor for neurotrophic keratitis. Ophthalmology. Jul 2000;107(7):1347-51; discussion 1351-2. [Medline].
Dohlman CH, Slansky HH, Laibson PR, et al. Artificial corneal epithelium in acute alkali burns. Ann Ophthalmol. 1969;112.
Kenyon KR, Berman M, Rose J, et al. Prevention of stromal ulceration in the alkali-burned rabbit cornea by glued-on contact lens. Evidence for the role of polymorphonuclear leukocytes in collagen degradation. Invest Ophthalmol Vis Sci. Jun 1979;18(6):570-87. [Medline].
Nubile M, Dua HS, Lanzini M, Ciancaglini M, Calienno R, Said DG, et al. In vivo analysis of stromal integration of multilayer amniotic membrane transplantation in corneal ulcers. Am J Ophthalmol. May 2011;151(5):809-822.e1. [Medline].
Yoon KC, You IC, Im SK, et al. Application of umbilical cord serum eyedrops for the treatment of neurotrophic keratitis. Ophthalmology. Sep 2007;114(9):1637-42. [Medline].
Alio JL, Abad M, Artola A, et al. Use of autologous platelet-rich plasma in the treatment of dormant corneal ulcers. Ophthalmology. Jul 2007;114(7):1286-1293.e1. [Medline].
Saika S, Miyamoto T, Yamanaka O, et al. Therapeutic effect of topical administration of SN50, an inhibitor of nuclear factor-kappaB, in treatment of corneal alkali burns in mice. Am J Pathol. May 2005;166(5):1393-403. [Medline].
Sosne G, Qiu P, Christopherson PL, et al. Thymosin beta 4 suppression of corneal NFkappaB: a potential anti-inflammatory pathway. Exp Eye Res. Apr 2007;84(4):663-9. [Medline].
Saika S, Yamanaka O, Okada Y, et al. Effect of overexpression of PPARgamma on the healing process of corneal alkali burn in mice. Am J Physiol Cell Physiol. Jul 2007;293(1):C75-86. [Medline].
Ioannidis AS, Zagora SL, Wechsler AW. A non-healing corneal ulcer as the presenting feature of type 1 diabetes mellitus: a case report. J Med Case Reports. Nov 4 2011;5(1):539. [Medline].
Albert DM, Jakobiec FA, eds. Principles and Practice of Ophthalmology. 2nd ed. Boston: WB Saunders Co; 2000.
Dua HS, Gomes JA, Singh A. Corneal epithelial wound healing. Br J Ophthalmol. May 1994;78(5):401-8. [Medline].
Geerling G, Joussen AM, Daniels JT, et al. Matrix metalloproteinases in sterile corneal melts. Ann N Y Acad Sci. Jun 30 1999;878:571-4. [Medline].
Gipson IK, Inatomi T. Extracellular matrix and growth factors in corneal wound healing. Curr Opin Ophthalmol. Aug 1995;6(4):3-10. [Medline].
He J, Bazan NG, Bazan HE. Alkali-induced corneal stromal melting prevention by a novel platelet-activating factor receptor antagonist. Arch Ophthalmol. Jan 2006;124(1):70-8. [Medline].
Imanishi J, Kamiyama K, Iguchi I, et al. Growth factors: importance in wound healing and maintenance of transparency of the cornea. Prog Retin Eye Res. Jan 2000;19(1):113-29. [Medline].
Kaufman HE, et al, eds. The Cornea. 2nd ed. Boston: Butterworth-Heinemann; 1998.
Nagano T, Nakamura M, Nakata K, et al. Effects of substance P and IGF-1 in corneal epithelial barrier function and wound healing in a rat model of neurotrophic keratopathy. Invest Ophthalmol Vis Sci. Sep 2003;44(9):3810-5. [Medline].
Watanabe M, Yano W, Kondo S, et al. Up-regulation of urokinase-type plasminogen activator in corneal epithelial cells induced by wounding. Invest Ophthalmol Vis Sci. Aug 2003;44(8):3332-8. [Medline].
Wilson SE, Liu JJ, Mohan RR. Stromal-epithelial interactions in the cornea. Prog Retin Eye Res. May 1999;18(3):293-309. [Medline].

